| HGNC Family | Non-coding RNAs |
| Name | microRNA 330 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMIR330, which exists as both the 3p and 5p mature forms, has emerged as a critical regulator in diverse biological processes, most notably in cancer. In several malignancies such as prostate, colorectal, and pancreatic cancers, reduced MIR330 expression exerts tumor‐suppressive effects by directly targeting key oncogenic mediators. For instance, in prostate cancer decreased MIR330 levels relieve inhibition of E2F1 and SP1—thereby promoting Akt phosphorylation and cell survival—and in colorectal cancer MIR330 negatively regulates oncogenes like Cdc42 and ITGA5, resulting in cell cycle arrest and apoptosis. Similar inhibitory roles have been observed in pancreatic cancer, acute myeloid leukemia, and even in inflammatory skin disorders like psoriasis, where MIR330 targets CTNNB1 to restrict keratinocyte proliferation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn contrast, context‐dependent studies indicate that MIR330 can also assume oncogenic properties. In glioblastoma stem cells and certain non‐small cell lung and pancreatic cancer models, overexpression of the MIR330 3p strand has been linked to enhanced proliferation, migration, and resistance to apoptosis. For example, elevated MIR330 expression in lung cancer has been shown to promote metastasis by targeting hSOD2, while in other settings its upregulation facilitates cell cycle progression through downregulation of EGR2. Moreover, in oesophageal adenocarcinoma, attenuation of MIR330‐5p is associated with subtle increases in radiotherapy resistance—highlighting the pleiotropic and context‐dependent functions of this microRNA."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its intrinsic functions, MIR330 activity is frequently modulated by interactions with long noncoding RNAs and circular RNAs, which act as molecular sponges to sequester MIR330 and thereby influence downstream oncogenic or tumor‐suppressive pathways. In melanoma, laryngeal, cervical, and ovarian cancers—as well as in non‐small cell lung and bladder cancers—such sponging by diverse circRNAs (e.g. circ_102179, circSEMA5A, circ_0000517) and lncRNAs (e.g. EWSAT1) leads to altered expression of targets including NOB1, S100A7, and RIPK4, ultimately affecting proliferation, epithelial–mesenchymal transition, and metastatic behavior. In addition, genetic variants affecting MIR330 regulation have been implicated in psychiatric mood and anxiety traits, and in nonmalignant conditions such as atherosclerosis and psoriasis MIR330 modulates inflammatory signaling cascades. Together, these studies underscore the nuanced, context‐dependent roles of MIR330 in governing cellular growth, differentiation, and stress responses."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "13", "end_ref": "31"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "K-H Lee, Y-L Chen, S-D Yeh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2009.192"}], "href": "https://doi.org/10.1038/onc.2009.192"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19597470"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19597470"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yuefeng Li, Xiaolan Zhu, Wenlin Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2013.01.016"}], "href": "https://doi.org/10.1016/j.bbrc.2013.01.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23337504"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23337504"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yeqing Mao, Hong Chen, Yiwei Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2013.2452"}], "href": "https://doi.org/10.3892/or.2013.2452"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23670210"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23670210"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Solange Tréhoux, Fatima Lahdaoui, Yannick Delpu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamcr.2015.05.033"}], "href": "https://doi.org/10.1016/j.bbamcr.2015.05.033"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26036346"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26036346"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Becky A S Bibby, John V Reynolds, Stephen G Maher "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0134180"}], "href": "https://doi.org/10.1371/journal.pone.0134180"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26221725"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26221725"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Haniyeh Fooladinezhad, Hossein Khanahmad, Mazdak Ganjalikhani-Hakemi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Negative regulation of TIM-3 expression in AML cell line (HL-60) using miR-330-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Biomed Sci (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/09674845.2016.1194564"}], "href": "https://doi.org/10.1080/09674845.2016.1194564"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27341144"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27341144"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Hye-In Yoo, Bong-Kyu Kim, Sungjoo Kim Yoon "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-330-5p negatively regulates ITGA5 expression in human colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2016.5092"}], "href": "https://doi.org/10.3892/or.2016.5092"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27633518"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27633518"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Hui Shen, Bijun Zeng, Chang Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-330 inhibits IL-22-induced keratinocyte proliferation through targeting CTNNB1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2017.05.005"}], "href": "https://doi.org/10.1016/j.biopha.2017.05.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28501007"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28501007"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Yilong Yao, Yixue Xue, Jun Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-330-mediated regulation of SH3GL2 expression enhances malignant behaviors of glioblastoma stem cells by activating ERK and PI3K/AKT signaling pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0095060"}], "href": "https://doi.org/10.1371/journal.pone.0095060"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24736727"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24736727"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Xuzhi Liu, Hanbing Shi, Bo Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-330-3p controls cell proliferation by targeting early growth response 2 in non-small-cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Biochim Biophys Sin (Shanghai) (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/abbs/gmv032"}], "href": "https://doi.org/10.1093/abbs/gmv032"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25935837"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25935837"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Lianghua Shen, Shanze Yi, Luyuan Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-330-3p promotes lung cancer cells invasion, migration, and metastasis by directly targeting hSOD2b."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biotechnol Appl Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/bab.1691"}], "href": "https://doi.org/10.1002/bab.1691"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30192404"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30192404"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Xingcheng Xiong, Qiao Shi, Xiaojia Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LINC00052 functions as a tumor suppressor through negatively modulating miR-330-3p in pancreatic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.28209"}], "href": "https://doi.org/10.1002/jcp.28209"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30712321"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30712321"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Kevin P Jensen, Henry R Kranzler, Murray B Stein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The effects of a MAP2K5 microRNA target site SNP on risk for anxiety and depressive disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet B Neuropsychiatr Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.b.32219"}], "href": "https://doi.org/10.1002/ajmg.b.32219"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24436253"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24436253"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Ranran Kong, Wei Liu, Yurui Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2017.5927"}], "href": "https://doi.org/10.3892/or.2017.5927"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28849232"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28849232"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Mei Lin, Bairong Xia, Ling Qin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "DNA Cell Biol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/dna.2017.3953"}], "href": "https://doi.org/10.1089/dna.2017.3953"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29485916"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29485916"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Zhenxin Zheng, Feng Bao, Xuhong Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-330-3p Expression Indicates Good Prognosis and Suppresses Cell Proliferation by Targeting Bmi-1 in Osteosarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000488612"}], "href": "https://doi.org/10.1159/000488612"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29614499"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29614499"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Ren Wang, Hui-Xing Dong, Jian Zeng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.26590"}], "href": "https://doi.org/10.1002/jcp.26590"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29663359"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29663359"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Nasser Sehati, Navaz Sadeghie, Behzad Mansoori, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-330 inhibits growth and migration of melanoma A375 cells: In vitro study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.29211"}], "href": "https://doi.org/10.1002/jcb.29211"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31237010"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31237010"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Becky A S Bibby, Cecelia S Miranda, John V Reynolds, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing microRNA-330-5p increases MMP1 expression and promotes an invasive phenotype in oesophageal adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-019-5996-3"}], "href": "https://doi.org/10.1186/s12885-019-5996-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31391080"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31391080"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "X Zhao, G-Q Chen, G-M Cao "}, {"type": "b", "children": [{"type": "t", "text": "Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201908_18728"}], "href": "https://doi.org/10.26355/eurrev_201908_18728"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31486488"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31486488"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Ying Cheng, Hui Zhu, Wei Gao "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-330-3p represses the proliferation and invasion of laryngeal squamous cell carcinoma through downregulation of Tra2β-mediated Akt signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Probes (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mcp.2020.101574"}], "href": "https://doi.org/10.1016/j.mcp.2020.101574"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32289378"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32289378"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Qingyan Zhou, Yuan Xie, Li Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA EWSAT1 upregulates CPEB4 via miR-330-5p to promote cervical cancer development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-020-03778-8"}], "href": "https://doi.org/10.1007/s11010-020-03778-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32556917"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32556917"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Ali Mohammadi, Behzad Mansoori, Pascal H G Duijf, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Restoration of miR-330 expression suppresses lung cancer cell viability, proliferation, and migration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.29840"}], "href": "https://doi.org/10.1002/jcp.29840"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32583462"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32583462"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Zhi-Feng Zhou, Zhi Wei, Jin-Chan Yao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircRNA_102179 promotes the proliferation, migration and invasion in non-small cell lung cancer cells by regulating miR-330-5p/HMGB3 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2020.153144"}], "href": "https://doi.org/10.1016/j.prp.2020.153144"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32911346"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32911346"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Lei Wang, Haoran Li, Qingdong Qiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circSEMA5A promotes bladder cancer progression by upregulating ENO1 and SEMA5A expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.103971"}], "href": "https://doi.org/10.18632/aging.103971"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33176280"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33176280"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Li Cai, Lu Ye, Xiaoqing Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.1871817"}], "href": "https://doi.org/10.1080/21655979.2021.1871817"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33487072"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33487072"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Cuijuan Qian, Shihang Chen, Sen Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circ_0000003 regulates glutamine metabolism and tumor progression of tongue squamous cell carcinoma via the miR‑330‑3p/GLS axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2021.7996"}], "href": "https://doi.org/10.3892/or.2021.7996"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33649795"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33649795"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Ying Qi, Jingni He, Ying Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2021.8001"}], "href": "https://doi.org/10.3892/or.2021.8001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33760216"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33760216"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Guanghua Qin, Xuejian Wu "}, {"type": "b", "children": [{"type": "t", "text": "Hsa_circ_0032463 acts as the tumor promoter in osteosarcoma by regulating the miR‑330‑3p/PNN axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2021.4925"}], "href": "https://doi.org/10.3892/ijmm.2021.4925"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33786605"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33786605"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Zhong-Xing Bing, Jia-Qi Zhang, Gui-Ge Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing of circ_0000517 suppresses proliferation, glycolysis, and glutamine decomposition of non-small cell lung cancer by modulating miR-330-5p/YY1 signal pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Kaohsiung J Med Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/kjm2.12440"}], "href": "https://doi.org/10.1002/kjm2.12440"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34405943"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34405943"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Zhifeng Shi, Zhixiong Zheng, Xiaodan Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long Noncoding RNA MALAT1 Regulates the Progression of Atherosclerosis by miR-330-5p/NF-κB Signal Pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cardiovasc Pharmacol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FJC.0000000000001061"}], "href": "https://doi.org/10.1097/FJC.0000000000001061"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34554676"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34554676"}]}]}]}
|
| Synonyms | MIRN330, MIR-330, HSA-MIR-330 |
| NCBI Gene ID | 442902 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR330 has 1,189 functional associations with biological entities spanning 5 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 19 datasets.
Click the + buttons to view associations for MIR330 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR330 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR330 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR330 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR330 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with MIR330 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR330 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR330 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR330 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR330 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR330 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MIR330 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MIR330 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with MIR330 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR330 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR330 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MIR330 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR330 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR330 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| WikiPathways Pathways 2014 | pathways involving MIR330 protein from the Wikipathways Pathways 2014 dataset. | |